<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Agios Pharmaceuticals, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Agios Pharmaceuticals, Inc.

    Agios is a biopharmaceutical company passionately committed to applying our scientific leadership in the field of cellular metabolism to transform the lives of patients with cancer and rare genetic diseases. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $542,000,000
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Jacqualyn Fouse, Ph.D.
    • FOUNDED
      2008
    • EMPLOYEES
      251-500
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Homology Medicines, Inc.

    Homology Medicines, Inc.

    Homology Medicines, Inc. is a genetic medicines company dedicated to transforming ...

    Homology Medicines, Inc. is a genetic medicines...

    Filing Type:    PU
    Jounce Therapeutics, Inc.

    Jounce Therapeutics, Inc.

    Jounce Therapeutics is a clinical stage immunotherapy company dedicated to transfo...

    Jounce Therapeutics is a clinical stage immunot...

    Filing Type:    PU
    PlantPharm BioMed, Ltd.

    PlantPharm BioMed, Ltd.

    We are a global frontrunner in making oral vaccines a reality. We’ve created a p...

    We are a global frontrunner in making oral vacc...

    Amount Raised:    $0.00
    Fundraising Status:    EC
    Filing Type:    CF
    ICON plc

    ICON plc

    Since our foundation in Dublin, Ireland in 1990, our mission has been to help our ...

    Since our foundation in Dublin, Ireland in 1990...

    Filing Type:    PU
    Vascular Biogenics Ltd.

    Vascular Biogenics Ltd.

    VBL Therapeutics is a publicly traded (NASDAQ: VBLT), late-stage clinical biopharm...

    VBL Therapeutics is a publicly traded (NASDAQ: ...

    Filing Type:    PU
    G1 Therapeutics, Inc.

    G1 Therapeutics, Inc.

    G1 Therapeutics, Inc., is a clinical-stage biopharmaceutical company focused on th...

    G1 Therapeutics, Inc., is a clinical-stage biop...

    Filing Type:    PU
    Pieris Pharmaceuticals, Inc.

    Pieris Pharmaceuticals, Inc.

    Pieris Pharmaceuticals, Inc. is a, clinical-stage biotechnology company committing...

    Pieris Pharmaceuticals, Inc. is a, clinical-sta...

    Filing Type:    PU
    Corcept Therapeutics Incorporated

    Corcept Therapeutics Incorporated

    Corcept is a pharmaceutical company engaged in the discovery, development and comm...

    Corcept is a pharmaceutical company engaged in ...

    Filing Type:    PU
    Unum Therapeutics Inc.

    Unum Therapeutics Inc.

    Unum Therapeutics is a clinical-stage biopharmaceutical company focused on develop...

    Unum Therapeutics is a clinical-stage biopharma...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.